nitroglycerin has been researched along with Hyperlipoproteinemia Type II in 8 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Twenty persons with cardiovascular risk (mean age 50+/-2 years) were treated with atorvastatin (80 mg/day) and FMD/NMD was measured during normoxia, hypoxia and oxygen supplementation before, after 1 day and 3 months." | 5.13 | Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk. ( Frøbert, O; Holmager, P; Jensen, KM; Schmidt, EB; Simonsen, U, 2008) |
| "01 mg of nitroglycerin (non-endothelium-dependent response) in 12 patients with blood hypertension (group 3), 10 subjects with family hypercholesterolemia (group 2) and 10 healthy subjects (group 1, control)." | 3.70 | [Noninvasive investigation of endothelial function in patients with hypertension and hypercholesterolemia (HCE)]. ( Alidzhanova, KhG; At'kov, OIu; Balakhonova, TV; Pogorelova, OA; Soboleva, GN, 1998) |
| "Evidence suggests that children with familial hypercholesterolemia (FH) have endothelial dysfunction." | 1.35 | Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. ( Antoniades, C; Charakida, M; Latsios, G; Pitsavos, C; Siasos, G; Skoumas, I; Stefanadi, E; Stefanadis, C; Tousoulis, D; Vasiliadou, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charakida, M | 1 |
| Tousoulis, D | 1 |
| Skoumas, I | 1 |
| Pitsavos, C | 1 |
| Vasiliadou, C | 1 |
| Stefanadi, E | 1 |
| Antoniades, C | 1 |
| Latsios, G | 1 |
| Siasos, G | 1 |
| Stefanadis, C | 1 |
| van Haelst, PL | 1 |
| van Doormaal, JJ | 1 |
| Asselbergs, FW | 1 |
| van Roon, AM | 1 |
| Veeger, NJ | 1 |
| Henneman, MM | 1 |
| Smit, AJ | 1 |
| Tervaert, JW | 1 |
| May, JF | 1 |
| Gans, RO | 1 |
| Järvisalo, MJ | 1 |
| Lehtimäki, T | 1 |
| Raitakari, OT | 1 |
| Miriyala, S | 1 |
| Gongora Nieto, MC | 1 |
| Mingone, C | 1 |
| Smith, D | 1 |
| Dikalov, S | 1 |
| Harrison, DG | 1 |
| Jo, H | 1 |
| Frøbert, O | 1 |
| Holmager, P | 1 |
| Jensen, KM | 1 |
| Schmidt, EB | 1 |
| Simonsen, U | 1 |
| Sorensen, KE | 1 |
| Celermajer, DS | 1 |
| Georgakopoulos, D | 1 |
| Hatcher, G | 1 |
| Betteridge, DJ | 1 |
| Deanfield, JE | 1 |
| Balakhonova, TV | 1 |
| Pogorelova, OA | 2 |
| Alidzhanova, KhG | 1 |
| Soboleva, GN | 1 |
| At'kov, OIu | 1 |
| Atkov, OY | 1 |
| Balahonova, TV | 1 |
2 trials available for nitroglycerin and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia.
Topics: Adult; Anticholesteremic Agents; Biomarkers; Brachial Artery; C-Reactive Protein; Cholesterol; Chole | 2003 |
Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk.
Topics: Administration, Inhalation; Adult; Atorvastatin; Brachial Artery; Cardiovascular Diseases; Cholester | 2008 |
6 other studies available for nitroglycerin and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.
Topics: Adolescent; Age Factors; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studi | 2009 |
Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness.
Topics: Adolescent; Brachial Artery; Carotid Arteries; Child; Diabetes Mellitus, Type 1; Endothelium, Vascul | 2004 |
Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation.
Topics: Acetophenones; Acetylcholine; Animals; Aorta, Thoracic; Apolipoproteins E; Bone Morphogenetic Protei | 2006 |
Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cholesterol; Endothelium, Vascular; Female; Femora | 1994 |
[Noninvasive investigation of endothelial function in patients with hypertension and hypercholesterolemia (HCE)].
Topics: Adolescent; Adult; Arteriosclerosis; Blood Flow Velocity; Brachial Artery; Endothelium, Vascular; Hu | 1998 |
Non-invasive ultrasound detection of endothelial dysfunction.
Topics: Adolescent; Adult; Blood Flow Velocity; Brachial Artery; Case-Control Studies; Endothelium, Vascular | 1998 |